Changeflow GovPing Government General Arrow Epidural Catheter Recall, Liquid Adhesive...
Urgent Enforcement Amended Final

Arrow Epidural Catheter Recall, Liquid Adhesive Defect, 190 Units

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

Arrow International LLC has initiated a Class II medical device recall for 190 units of FLEXTIP PLUS Epidural Catheters and FLEXBLOCK Continuous Peripheral Nerve Block Catheter Kits (REF ASK-05502-BSM, Batch 33F25K0409). The recall was triggered when supplier Ferndale Laboratories disclosed that a lot of Mastisol Liquid Adhesive was exposed to a double sterilization cycle, causing the butyrate tubing to crack during actuation. The FDA determined the root cause is process control failure. Affected medical facilities must immediately cease use, quarantine the product, and return it to Teleflex for credit.

“Medical Facilities should: 1. Immediately check inventory for product within the scope of this recall and cease use and distribution of affected product and immediately quarantine the affected product.”

FDA , verbatim from source
Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors FDA Device Recalls (Class II) for new government general regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 90 changes logged to date.

What changed

This Class II recall affects 190 units of Arrow epidural and peripheral nerve block catheters distributed to nine states (AZ, CA, GA, MA, ME, MI, OR, PA, VA). The root cause is a supplier manufacturing error where Mastisol Liquid Adhesive was exposed to a double sterilization cycle, making the butyrate tubing brittle and prone to cracking during actuation. FDA determined the root cause is process control failure.\n\nMedical facilities holding affected product must immediately cease use, quarantine inventory, and complete Teleflex's acknowledgement form to initiate return and credit. Distributors must forward the recall notice to all downstream customers and facilitate product returns. Teleflex will issue a credit note upon receipt of returned affected product.

What to do next

  1. Immediately check inventory for product within the scope of this recall and cease use and distribution of affected product and immediately quarantine the affected product
  2. Contact Teleflex Customer Service utilizing one of the following methods: Fax, including Attn: Customer Service, or email customer service using the point of contact details outlined on Page 3 with a copy of Appendix 1 OR using the online FSN Portal, complete the acknowledgement form virtually using the following link: https://fca.myteleflex.com/en/recall/000606
  3. Return the form to Teleflex at the contact details provided

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall FLEXTIP PLUS EPIDURAL CATHETER;FLEXBLOCK CONTINOUS PERIPHERAL NERVE BLOCK CATHETER KIT/SET

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall FLEXTIP PLUS EPIDURAL CATHETER;FLEXBLOCK CONTINOUS PERIPHERAL NERVE BLOCK CATHETER KIT/SET | |

Date Initiated by Firm March 11, 2026
Date Posted April 22, 2026
Recall Status Open , Classified
Recall Number Z-1913-2026
Recall Event ID 98618
510(K)Number K140110
Product Classification Catheter, conduction, anesthetic - Product Code BSO
Product FLEXTIP PLUS EPIDURAL CATHETER;FLEXBLOCK CONTINOUS PERIPHERAL NERVE BLOCK CATHETER KIT/SET REF ASK-05502-BSM

UDI code: (01)10801902209853(17)270831(11)251210(10)33F25K0409

The Arrow Epidural Catheter kit permits access to the epidural space for administration of
epidural anesthetic. The epidural catheter kit is intended for use up to 72 hours.
The Arrow Combined Spinal Anesthesia and Epidural Catheterization products
permit access to subarachnoid and epidural spaces.
The Arrow Single Shot Epidural product permits access to the epidural space.. |
| Code Information | Product code:ASK-05502-BSM
UDI code: (01)10801902209853(17)270831(11)251210(10)33F25K0409
Batch Number: 33F25K0409 |
| FEI Number | 3013162291 |
| Recalling Firm/
Manufacturer | ARROW INTERNATIONAL, LLC
3015 Carrington Mill Blvd
Morrisville NC 27560-5437 |
| Manufacturer Reason
for Recall | Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured |
| FDA Determined
Cause | Process control |
| Action | On 03/18/2026, the firm sent via FedEx-2-day an "URGENT MEDICAL DEVICE RECALL" Letter informing customers that Ferndale Laboratories issued a Field Safety Notice (FSN) to inform users of multiple complaints reporting the butyrate tubing of the Mastisol Liquid Adhesive vial cracked during actuation. According to the Ferndale Laboratories FSN, one lot of MASTISOL Liquid Adhesive was exposed to a double sterilization cycle which may have contributed to the butyrate tubing becoming brittle and susceptible to cracking during actuation.

Medical Facilities should:
1. Immediately check inventory for product within the scope of this recall and cease use and distribution of affected product and immediately quarantine the affected product.
2. For impacted product, mark the applicable checkbox on the Acknowledgement
Form (Appendix 1) and contact Teleflex Customer Service utilizing one of the following
methods:
a. Fax, including Attn: Customer Service , or email customer service using the point of
contact details outlined on Page 3 with a copy of Appendix 1
OR
b. Using the online FSN Portal, complete the acknowledgement form virtually using the
following link: https://fca.myteleflex.com/en/recall/000606
Note: Option B is solely applicable to customers who received product direct from
Teleflex.
3. For impacted product, mark the applicable checkbox on the Acknowledgement Form (Appendix 1) and return the form to Teleflex at the contact details provided.
4. Teleflex (or your local dealer) will issue a credit note upon receipt of the returned affected product.

Distributor should:
1. Provide a copy of this recall notice to all customers who have received impacted product. Each customers is then required to complete the Acknowledgement Form and return it to Distributor.
2. Request immediate check of inventory, cease use and distribution of, and quarantine, affected products and returned to Teleflex.

For questions-contact customer service at 1-866-396-2111 or email Recalls@telefle |
| Quantity in Commerce | 190 |
| Distribution | U.S. Nationwide distribution in the states of AZ, CA, GA, MA, ME, MI, OR, PA, and VA. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

| 510(K) Database | 510(K)s with Product Code = BSO |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 11th, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Product recall response Medical device distribution Quality control
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!